Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous or infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was incorporated in 2007 and is based in Abingdon, United Kingdom.

Philadelphia, US
Size (employees)
173 (est)
Adaptimmune was founded in 2008 and is headquartered in Philadelphia, US

Adaptimmune Office Locations

Adaptimmune has offices in Philadelphia and Milton
Philadelphia, US (HQ)
2010 Market St
Milton, GB
Park House Park Dr

Adaptimmune Data and Metrics

Adaptimmune Financial Metrics

Adaptimmune's revenue was reported to be $9 m in FY, 2016
Numbers are in $, USD

Revenue (FY, 2016)

9 m

Net income (FY, 2016)

(23 m)

EBIT (FY, 2016)

(26.4 m)

Market capitalization (28-Apr-2017)

381.6 m

Closing share price (28-Apr-2017)


Cash (31-Dec-2016)

158.8 m
Adaptimmune's current market capitalization is $381.6 m.
Numbers are in $, USDFY, 2016


9 m

R&D expense

(25.5 m)

General and administrative expense

(9.9 m)

Operating expense total

(35.4 m)


(26.4 m)

EBIT margin, %


Interest income

489 k

Pre tax profit

(23.1 m)

Income tax expense

55 k

Net Income

(23 m)
Numbers are in $, USDFY, 2016


158.8 m

Accounts Receivable

149.5 k


1.4 m

Current Assets

198.8 m


27.9 m

Total Assets

234.5 m

Accounts Payable

11.4 m

Current Liabilities

40.3 m

Additional Paid-in Capital

341.2 m

Retained Earnings

(161.5 m)

Total Equity

166.1 m

Financial Leverage

1.4 x
Numbers are in $, USDFY, 2016

Net Income

(23 m)

Cash From Operating Activities

(48.2 m)

Cash From Investing Activities

17.8 m

Cash From Financing Activities

17 k
Numbers are in $, USDY, 2016


51.9 k

Financial Leverage

1.4 x

Adaptimmune Operating Metrics

FY, 2016

Patent Applications


Patents Granted


Adaptimmune Online and Social Media Presence

Adaptimmune News and Updates

Adaptimmune Company Life and Culture

You may also be interested in